3D Systems Beheer
Beheer criteriumcontroles 4/4
De CEO 3D Systems is Jeff Graves, benoemd in May2020, heeft een ambtstermijn van 6.33 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 1.49M, bestaande uit 57.1% salaris en 42.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.79% van de aandelen van het bedrijf, ter waarde $ 4.30M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.8 jaar en 7.1 jaar.
Belangrijke informatie
Jeff Graves
Algemeen directeur
US$1.5m
Totale compensatie
| Percentage CEO-salaris | 57.11% |
| Dienstverband CEO | 6.3yrs |
| Eigendom CEO | 0.8% |
| Management gemiddelde ambtstermijn | 3.8yrs |
| Gemiddelde ambtstermijn bestuur | 7.1yrs |
Recente managementupdates
Recent updates
Narratiefupdate • Sep 03
DDD: Leaner Cost Base And New Orders Will Support Future Margins
Analysts raised their fair value estimate for 3D Systems to $5.50 from $4.00, citing a lower assumed discount rate, higher modeled revenue growth, slightly stronger profit margins, and a richer future P/E multiple that reflects recent research indicating a potential new growth cycle and a leaner cost structure. Analyst Commentary Recent research on 3D Systems points to a company that some see as moving into a new phase, with a leaner cost base and a clearer path to growth.
Narratiefupdate • Aug 19
DDD: Turnaround Progress And CEO Transition Will Shape Next Growth Phase
Analysts have raised their price target on 3D Systems from $3 to $6, citing improved Q2 results, a lower cost structure, EBITDA breakeven, and new growth opportunities highlighted by the company’s largest polymer 3D printing order since 2014, as well as guidance for mid to high single digit Q3 revenue growth. Analyst Commentary on 3D Systems Recent commentary around 3D Systems highlights a mix of optimism about the company’s operational reset and caution around execution and leadership change.Seeking Alpha • Aug 10
3D Systems: Recovery Is Gaining Momentum, But Valuation Leaves Little Room For Error
Summary 3D Systems Corporation outlook has improved due to a demand recovery in dental, manufacturing CapEx, and defense. While Q3 guidance is soft, 3D Systems' core business is likely to continue accelerating in coming quarters. Cost-cutting efforts and operating leverage should see 3D Systems' approach breakeven in coming quarters. Long-term profitability remains a key uncertainty though. While 3D Systems' fundamentals are improving, this is already largely priced in. As a result I am fairly neutral on DDD stock. Read the full article on Seeking Alpha
Narratiefupdate • Aug 04
DDD: Polymer Order And Leaner Cost Base Will Support Future Earnings Power
Analysts have lifted their 3D Systems price target from $5 to $6, citing improved Q2 results, a leaner cost structure, fresh growth opportunities including the largest polymer 3D printing order since 2014, and updated guidance for mid to high single digit Q3 revenue growth, even as a surprise CEO transition adds an extra variable to the story. Analyst Commentary Bullish analysts see the recent shift in sentiment around 3D Systems as tied to both execution and a clearer path to potential growth.Narratiefupdate • Jun 18
DDD: Follow-On Equity Offerings Will Pressure Stock Despite Higher Fair Value
Analysts have increased their price target for 3D Systems stock from $2.50 to $3.00, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that together support a higher assessed fair value. What’s in the News for 3D Systems 3D Systems filed a follow-on equity offering for approximately $40 million in common stock, according to company filings.Narratiefupdate • Jun 04
DDD: Capital Raises And Dental Expansion Will Support Margins With Balanced Risk
Analysts have raised their price target on 3D Systems from $3.63 to $4.00, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E, which they view as better reflecting the company’s current risk and return profile. What's in the News The company filed a follow-on equity offering of US$40 million in common stock, followed by completion of a separate common stock offering of about US$50.0 million, covering 16,393,443 shares at US$3.05 per share.Narratiefupdate • May 06
DDD: Dental Solutions And Factory Software Will Support Future Earnings Power
Analysts have slightly lowered their price target on 3D Systems to $5.00, citing modest adjustments to the discount rate, revenue growth, profit margin expectations, and assumed future P/E. Together, these factors point to a more cautious but still constructive view on the stock's valuation.Narratiefupdate • Apr 22
DDD: New CFO And Industrial Expansion Will Support Future Earnings Power
Analysts have made a slight adjustment to their price target on 3D Systems, reflecting updated assumptions about the discount rate, revenue growth, profit margins, and future P/E. This has led to a modest recalibration of fair value, with their target remaining close to $5.00 per share.Narratiefupdate • Apr 07
DDD: New CFO And Dental Expansion Will Support Future Earnings Power
Analysts have maintained their price target for 3D Systems at $5.00, reflecting only minor adjustments to assumptions related to discount rate, revenue growth, profit margin, and future P/E, which together support an unchanged valuation view. What's in the News Phyllis Nordstrom is set to become Chief Financial Officer on March 23, 2026, after serving as Interim CFO since August 2025, while continuing as Chief Administrative Officer reporting to President and CEO Dr. Jeffrey Graves (Key Developments).Narratiefupdate • Mar 24
DDD: Dental Solutions Expansion And New CFO Will Support Future Earnings Power
Analysts now set a higher price target of $5.00 for 3D Systems, up from $4.75, citing updated assumptions for revenue growth, profit margins, a lower discount rate, and a higher future P/E multiple. What's in the News Phyllis Nordstrom is appointed Chief Financial Officer, effective March 23, 2026, after serving as Interim CFO since August 2025.Narratiefupdate • Mar 09
DDD: Expanded Med Tech Indications And Digital Dentures Will Support Margin Upside
Analysts have slightly trimmed their price target on 3D Systems to $3.63, reflecting small tweaks to assumptions around discount rate, profit margin and future P/E, while keeping their fair value view broadly in line. What's in the News 3D Systems introduced three new NextDentJet Base shades for its NextDent Jetted Denture Solution, adding Dark Pink, Light Pink, and Red Pink to the existing Light Tone option to better match a range of natural gum tones.Narratiefupdate • Feb 22
DDD: Expanded Dental And Orthopedic Applications Will Support Higher Margin Confidence
Analysts have maintained their $3.63 fair value estimate for 3D Systems, with only minor adjustments to inputs, including a slightly higher discount rate and modestly lower profit margin assumptions, shaping this latest price target update. What's in the News 3D Systems introduced three new NextDentJet Base shades: Dark Pink, Light Pink, and Red Pink, expanding its NextDent Jetted Denture Solution to four base shades aimed at better matching a wider range of natural gum tones across patient populations.Narratiefupdate • Feb 08
DDD: Expanded Med Tech Indications Will Support Higher Margin Confidence
Analysts have adjusted their price targets on 3D Systems slightly, with modest tweaks to the discount rate, profit margin expectations, and forward P/E assumptions, leading to a refined view of fair value for the shares. What's in the News FDA granted 510(k) clearance expanding indications for 3D Systems' VSP Orthopedics platform to include skeletally mature adolescents of normal bone stature, moving prior off label use for these patients into standard, reimbursable procedures at leading centers (Key Developments).Narratiefupdate • Jan 24
DDD: Margin Execution And Med Tech Expansion Will Support Higher Confidence
Analysts have raised their price target on 3D Systems to US$4.75 from US$4.00. This reflects updated views on the company's margin outlook and valuation multiples.Narratiefupdate • Jan 10
DDD: Expanded Med Tech Margins And Execution Will Support Greater Market Confidence
Analysts lifted their price target on 3D Systems to $4.75 from $4.00, reflecting updated assumptions around discount rates, profit margins and future P/E multiples that influence their valuation outlook. Analyst Commentary Recent research reflects a modestly more constructive stance on 3D Systems, with the updated US$4.75 price target framing how some on the Street view the balance of risk and reward.Analyse-artikel • Jan 09
There's No Escaping 3D Systems Corporation's (NYSE:DDD) Muted Revenues Despite A 45% Share Price Rise
3D Systems Corporation ( NYSE:DDD ) shareholders are no doubt pleased to see that the share price has bounced 45% in...Narratiefupdate • Dec 26
DDD: Med Tech And Industrial Demand Will Drive Improved Earnings Power
Analysts have raised their price target on 3D Systems to $4.75 from $4.00, reflecting improved expectations for a return to revenue growth and a slightly higher assumed future earnings multiple, despite a modestly higher discount rate. Analyst Commentary Bullish analysts highlight that the new price target reflects growing confidence in 3D Systems’ ability to stabilize its core business and return to sustainable top line expansion.Narratiefupdate • Dec 12
DDD: Execution On New Products And Cost Discipline Will Drive Confidence
Analysts have modestly increased their price target for 3D Systems to $4.75 from $4.00, citing a slightly higher assumed future earnings multiple and a marginally higher discount rate while leaving long term growth and margin expectations effectively unchanged. Analyst Commentary Analysts view the modest price target increase as a reflection of slightly improved confidence in 3D Systems' ability to execute on its strategy, while still recognizing meaningful execution and market risks at current levels.Narratiefupdate • Nov 27
DDD: Margin Stability And Cost Discipline Will Drive Confidence In 2025
Analysts have raised their price target on 3D Systems from $4.00 to $4.75, citing shifts in projected discount rates and modest adjustments to revenue growth expectations as core reasons for their updated outlook. Analyst Commentary Analyst sentiment on 3D Systems has shifted following recent developments, prompting a closer examination of both the company’s growth potential and the associated risks.Analyse-artikel • Nov 12
3D Systems' (NYSE:DDD) Profits Appear To Have Quality Issues
The stock price didn't jump after 3D Systems Corporation ( NYSE:DDD ) posted decent earnings last week. We did some...Narratiefupdate • Nov 09
DDD: Margin Strength And New Contract Will Drive Outperformance Ahead
Analysts have increased their price target for 3D Systems from $3.25 to $3.63. They cite improved revenue growth and a significant strengthening of profit margins as key factors driving the outlook higher.Analyse-artikel • Nov 08
Benign Growth For 3D Systems Corporation (NYSE:DDD) Underpins Stock's 31% Plummet
The 3D Systems Corporation ( NYSE:DDD ) share price has softened a substantial 31% over the previous 30 days, handing...Analyse-artikel • Sep 24
3D Systems Corporation (NYSE:DDD) Shares Fly 34% But Investors Aren't Buying For Growth
Despite an already strong run, 3D Systems Corporation ( NYSE:DDD ) shares have been powering on, with a gain of 34% in...Narratiefupdate • Aug 15
Healthcare Customization And Additive Manufacturing Will Forge A Resilient Future
As 3D Systems’ net profit margin and revenue growth forecasts remain unchanged at 0.72% and -4.5% respectively, the analyst consensus price target is also maintained at $3.25. What's in the News 3D Systems launched the NextDent Jetted Denture Solution and NextDent 300 MultiJet printer in the U.S., enabling rapid, post-cure-free, single-piece, dual-material dentures with improved aesthetics and durability.Seeking Alpha • Apr 14
3D Systems: Restructuring And The Challenging Path To Turnaround
Summary 3D Systems face revenue decline and margin pressures due to manufacturing sector weakness and high-interest rates, leading to a -10.5% revenue CAGR from FY21 to FY24. Management's restructuring plan includes a $50 million cost-cutting program and the sale of Geomagic software, but breakeven requires significant revenue growth and an industry rebound. Comparison with Stratasys and Nano Dimension shows 3D Systems' underperformance in revenue, margins, and debt, with a steep stock price decline of 86.42% since January 2022. Despite restructuring efforts, high competition and past acquisition strategy raise doubts about achieving profitability, leading to a "hold" rating for 3D Systems. Read the full article on Seeking Alpha
Nieuw narratief • Mar 29
Regenerative Medicine And Dental Focus Will Open New Markets
Collaborations in regenerative medicine and dental market focus position 3D Systems for potential future revenue growth.Analyse-artikel • Feb 13
A Piece Of The Puzzle Missing From 3D Systems Corporation's (NYSE:DDD) 39% Share Price Climb
Despite an already strong run, 3D Systems Corporation ( NYSE:DDD ) shares have been powering on, with a gain of 39% in...Seeking Alpha • Jan 31
3D Systems: A Strong One For Speculative Investors
Summary 3D Systems is a leader in 3D printing with diverse technologies, excelling in medical, aerospace, and automotive sectors, despite financial challenges. The company is investing in bioprinting and custom implants, with valuable partnerships in defense and aerospace, driving future growth. Revenue is expected to decline in 2024 due to macroeconomic conditions, but operational efficiency and new product launches show promise. Investors with high-risk tolerance may consider 3D Systems for speculative growth, while conservative investors should wait for stable profitability. Read the full article on Seeking AlphaAnalyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | -US$55m |
| Mar 31 2026 | n/a | n/a | US$62m |
| Dec 31 2025 | US$1m | US$850k | US$30m |
| Sep 30 2025 | n/a | n/a | US$16m |
| Jun 30 2025 | n/a | n/a | -US$145m |
| Mar 31 2025 | n/a | n/a | -US$277m |
| Dec 31 2024 | US$2m | US$850k | -US$256m |
| Sep 30 2024 | n/a | n/a | -US$515m |
| Jun 30 2024 | n/a | n/a | -US$348m |
| Mar 31 2024 | n/a | n/a | -US$350m |
| Dec 31 2023 | US$7m | US$850k | -US$363m |
| Sep 30 2023 | n/a | n/a | -US$96m |
| Jun 30 2023 | n/a | n/a | -US$122m |
| Mar 31 2023 | n/a | n/a | -US$126m |
| Dec 31 2022 | US$6m | US$850k | -US$123m |
| Sep 30 2022 | n/a | n/a | -US$104m |
| Jun 30 2022 | n/a | n/a | US$227m |
| Mar 31 2022 | n/a | n/a | US$250m |
| Dec 31 2021 | US$9m | US$837k | US$322m |
| Sep 30 2021 | n/a | n/a | US$308m |
| Jun 30 2021 | n/a | n/a | -US$57m |
| Mar 31 2021 | n/a | n/a | -US$85m |
| Dec 31 2020 | US$6m | US$489k | -US$150m |
Compensatie versus markt: De totale vergoeding ($USD 1.49M ) Jeff } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 2.41M ).
Compensatie versus inkomsten: De vergoeding van Jeff is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Jeff Graves (65 yo)
6.3yrs
Tenure
US$1,487,950
Compensatie
Dr. Jeffrey Alan Graves, also known as Jeff, Ph D., is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023.Dr. Grav...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 6.3yrs | US$1.49m | 0.79% $ 4.3m | |
| Co-Founder | no data | US$527.51k | 0.31% $ 1.7m | |
| Executive VP | 3.7yrs | US$1.65m | 0.48% $ 2.6m | |
| Executive Vice President of Engineering & Operations | 3.8yrs | US$638.97k | 0.17% $ 909.2k | |
| Executive VP of Additive Solutions & Chief Commercial Officer | 6.2yrs | US$830.05k | 0.30% $ 1.6m | |
| Senior VP of General Counsel & Corporate Secretary | 2.3yrs | geen gegevens | 0.086% $ 466.9k |
3.8yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van DDD wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 6.7yrs | US$1.49m | 0.79% $ 4.3m | |
| Co-Founder | 4.3yrs | US$527.51k | 0.31% $ 1.7m | |
| Independent Director | 30.7yrs | US$203.49k | 0.34% $ 1.8m | |
| Member of Medical Advisory Board | 4.3yrs | geen gegevens | geen gegevens | |
| Independent Director | 10.8yrs | US$218.49k | 0.24% $ 1.3m | |
| Independent Director | 26.9yrs | US$233.49k | 0.19% $ 1.0m | |
| Independent Chairman of the Board | 9.5yrs | US$388.49k | 0.14% $ 745.1k | |
| Independent Director | 9.3yrs | US$233.49k | 0.14% $ 740.5k | |
| Chair of Medical Advisory Board | 4.3yrs | geen gegevens | geen gegevens | |
| Independent Director | 7.5yrs | US$218.49k | 0.12% $ 656.2k | |
| Independent Director | 5.8yrs | US$218.49k | 0.12% $ 630.8k | |
| Independent Director | 4.8yrs | US$247.73k | 0.10% $ 570.2k |
7.1yrs
Gemiddelde duur
71.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van DDD wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.1 jaar).
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/11 13:04 |
| Aandelenkoers aan het einde van de dag | 2026/09/11 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
3D Systems Corporation wordt gevolgd door 26 analisten. 4 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Benjamin Reitzes | Barclays |
| Kenneth Vallace | Berenberg |
| Wamsi Mohan | BofA Global Research |